IDT Australia Limited (AU:IDT) has released an update.
IDT Australia Limited reported a substantial revenue increase of 101% to $14.1M in FY24, with significant contributions from its three main verticals: API manufacturing, Specialty Orals, and Advanced Therapies, which saw growth of 227%, 20%, and 415%, respectively. The company also made strides towards profitability with a notable decrease in losses in the second half of the year, while maintaining a strong sales pipeline valued at $25M in client proposals. This performance marks a pivotal moment in IDT’s strategic transformation, positioning the company for further growth in FY25.
For further insights into AU:IDT stock, check out TipRanks’ Stock Analysis page.
